D. L. Larson

发表

Operational evaluation of a 150 kW solar thermal power plant

D. L. Larson, 1981 .

Feasibility of solar energy for feedlot operation and irrigation pumping. Final report 1 May 75-31 Dec 76

J. H. Strickland, A. F. Hildebrandt, D. L. Larson, 1977 .

Electric utility load management policies and groundwater irrigation pumping for agriculture

D. E. Agthe, D. L. Larson, 1986 .

Energy in Irrigated Crop Production

D. D. Fangmeier, D. L. Larson, 1978 .

ENERGY AND EXERGY EVALUATION OF ICE PRODUCTION BY ABSORPTION REFRIGERATION

D. L. Larson, L. A. B. Cortez, A. da Silva, 1997 .

LIMS: a suite of database tools for laboratory organization

D. L. Larson, M. S. Hilliard, M. J. Rosenberg, 2001, Proceedings 14th IEEE Symposium on Computer-Based Medical Systems. CBMS 2001.

Coolidge solar powered irrigation pumping project

D. L. Larson, 1980 .

Opioid agonist and antagonist bivalent ligands as receptor probes.

D. L. Larson, P. Portoghese, A. Takemori, 1982, Life sciences.

Hybrid bivalent ligands with opiate and enkephalin pharmacophores.

D. L. Larson, P. Schiller, P. Portoghese, 1987, Journal of medicinal chemistry.

Stereostructure-activity relationship of opioid agonist and antagonist bivalent ligands. Evidence for bridging between vicinal opioid receptors.

D. L. Larson, K. Rice, A. Lipkowski, 1985, Journal of medicinal chemistry.

Opioid Agonist and Antagonist Bivalent Ligands. The Relationship between Spacer Length and Selectivity at Multiple Opioid Receptors.

D. L. Larson, P. Portoghese, A. Takemori, 1987 .

Opioid antagonist activity of naltrexone-derived bivalent ligands: importance of a properly oriented molecular scaffold to guide "address" recognition at kappa opioid receptors.

D. L. Larson, M. Bolognesi, P. Portoghese, 1996, Journal of medicinal chemistry.

Opioid agonist and antagonist activities of peripherally selective derivatives of naltrexamine and oxymorphamine.

D. L. Larson, Peter A. Stark, A. Lipkowski, 1989, Journal of medicinal chemistry.

Binding of norbinaltorphimine (norBNI) congeners to wild-type and mutant mu and kappa opioid receptors: molecular recognition loci for the pharmacophore and address components of kappa antagonists.

D. L. Larson, R. M. Jones, T. Schwartz, 2000, Journal of medicinal chemistry.

Synthesis and opioid antagonist potencies of naltrexamine bivalent ligands with conformationally restricted spacers.

D. L. Larson, P. Portoghese, A. Takemori, 1986, Journal of Medicinal Chemistry.

A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities.

D. L. Larson, P. Portoghese, A. Takemori, 1980, Journal of medicinal chemistry.

Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity.

D. L. Larson, A. Lipkowski, P. Portoghese, 1988, Journal of medicinal chemistry.

Synthesis of 7-arylmorphinans. Probing the "address" requirements for selectivity at opioid delta receptors.

D. L. Larson, P. Portoghese, P. Gao, 1998, Journal of medicinal chemistry.

Persistent binding of fatty acyl derivatives of naltrexamine to opioid receptors.

D. L. Larson, P. Portoghese, A. Garzon-Aburbeh, 1991, Journal of medicinal chemistry.

Stereochemical studies on medicinal agents. 12. The distinction of enantiotopic groups in the interaction of 1-methyl-4-phenyl-4-propionoxypiperidine with analgetic receptors.

D. L. Larson, P. Portoghese, D L Larson, 1973, Journal of medicinal chemistry.

Opioid receptor binding characteristics of the non-equilibrium μ antagonist, β-funaltrexamine (β-FNA)☆

D. L. Larson, P. Portoghese, A. Takemori, 1985 .

Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different mu receptor subtypes in different tissues.

D. L. Larson, P. Portoghese, A. Takemori, 1984, Journal of medicinal chemistry.

Chloroxymorphamine, and opioid receptor site-directed alkylating agent having narcotic agonist activity.

D. L. Larson, P. Portoghese, A. Takemori, 1979, Science.

Isolation of selective 3H-chlornaltrexamine-bound complexes, possible opioid receptor components in brains of mice.

D. L. Larson, P. Portoghese, A. Takemori, 1980, Life sciences.

Synthesis and pharmacologic characterization of an alkylating analogue (chlornaltrexamine) of naltrexone with ultralong-lasting narcotic antagonist properties.

D. L. Larson, P. Portoghese, A. Takemori, 1979, Journal of medicinal chemistry.

Pharmacological studies with an alkylating narcotic agonist, chloroxymorphamine, and antagonist, chlornaltrexamine.

D. L. Larson, P. Portoghese, A. Takemori, 1980, The Journal of pharmacology and experimental therapeutics.

IMPORTANCE OF CARBON 6 CHIRALITY IN CONFERRING IRREVERSIBLE OPIOID ANTAGONISM TO NALTREXONE-DERIVED AFFINITY LABELS

D. L. Larson, P. Portoghese, A. Takemori, 1984 .

Importance of C-6 chirality in conferring irreversible opioid antagonism to naltrexone-derived affinity labels.

D. L. Larson, P. Portoghese, A. Takemori, 1983, Journal of medicinal chemistry.

6β-(N,N-BIS(2-CHLOROETHYL)AMINO)-17-(CYCLOPROPYLMETHYL)-4,5α-EPOXY-3# ,14-DIHYDROXYMORPHINAN (CHLORANALTREXAMINE), A POTENT OPIOID RECEPTOR ALKYLATING AGENT WITH ULTRALONG NARCOTIC ANTAGONIST ACTIVITY

D. L. Larson, P. Portoghese, A. Takemori, 1978 .

Opioid agonist and antagonist bivalent ligands. The relationship between spacer length and selectivity at multiple opioid receptors.

D. L. Larson, P. Portoghese, A. Takemori, 1986, Journal of medicinal chemistry.

Allylprodine analogues as receptor probes. Evidence that phenolic and nonphenolic ligands interact with different subsites on identical opioid receptors.

D. L. Larson, P. Portoghese, B. D. Alreja, 1981, Journal of medicinal chemistry.

Stereochemical studies on medicinal agents. 13. Correlation of the solid-state conformations of 1,3,5-trimethyl- and 1,3-dimethyl-4-phenyl-4-propionoxypiperidine enantiomers with their absolute stereoselectivity at analgetic receptors.

D. L. Larson, P. Portoghese, Z. Gomaa, 1973, Journal of medicinal chemistry.

Synthesis, X-ray crystallographic determination, and opioid activity of erythro-5-methylmethadone enantiomers. Evidence which suggests that mu and delta opioid receptors possess different stereochemical requirements.

D. L. Larson, J. Poupaert, W. Duax, 1982, Journal of medicinal chemistry.

STEREOCHEMICAL STUDIES ON MEDICINAL AGENTS. I. ABSOLUTE CONFIGURATION OF CERTAIN ANALGESIC (-)-N-(2-(PHENALKYLMETHYLAMINO)PROPYL)PROPIONANILIDES.

D. L. Larson, P. Portoghese, 1964, Journal of pharmaceutical sciences.

Inhibition of substance P release from spinal cord tissue after pretreatment with capsaicin does not mediate the antinociceptive effect of capsaicin in adult mice

D. L. Larson, A. Larson, P. Portoghese, 1997, Pain.

7-Spiroindanyl derivatives of naltrexone and oxymorphone as selective ligands for delta opioid receptors.

D. L. Larson, P. Portoghese, A. Takemori, 1997, Journal of medicinal chemistry.

Absolute stereochemistry and analgesic potency of prodine enantiomers.

D. L. Larson, P. Portoghese, 1968, Journal of pharmaceutical sciences.

Transfer of fatty acyl groups from membrane phosphatides to opiate ligands

D. L. Larson, A. Lipkowski, P. Portoghese, 1989, Neurochemistry International.

Relation between analgetic ED50 dose and time-course brain levels of N-alkylnormeperidine homologs

D. L. Larson, P. Portoghese, 1976 .

A convenient, general procedure for preparing specifically [3H]-labeled amines. Synthesis of [3H]-meperidine hydrochloride.

D. L. Larson, P. Portoghese, 1973, Journal of medicinal chemistry.

The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone.

D. L. Larson, P. Portoghese, A. Takemori, 1981, European journal of pharmacology.

7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands.

D. L. Larson, P. Portoghese, X. Fang, 1997, Journal of medicinal chemistry.

Conformational analysis and automated receptor docking of selective arylacetamide-based kappa-opioid agonists.

D. L. Larson, D. Ferguson, G. Subramanian, 1998, Journal of medicinal chemistry.

Opioid agonist and antagonist activities of morphindoles related to naltrindole.

D. L. Larson, P. Portoghese, M. Sultana, 1992, Journal of medicinal chemistry.